Chinese Medicine Meets Conventional Medicine in Targeting COVID-19 Pathophysiology,Complications and Comorbidities

分享到

【作者】WANG Shan-shan，ZENG Xian，WANG Ya-li，Zhuoma Dongzhi，ZHAO Yu-fen，CHEN Yu-zong
【作者单位】Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences，Institute of Drug Discovery Technology，Ningbo University；Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics，Fudan University School of Pharmacy；Bioinformatics and Drug Design Group，Department of Pharmacy，National University of Singapore；Medical College，Tibet University；Department of Chemical Biology，College of Chemistry and Chemical Engineering，and The Key Laboratory for Chemical Biology of Fujian Province，Xiamen University；Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology (Ministry of Education)，Department of Chemistry，Tsinghua University
【年份】2022
【卷号】第28卷
【期号】第7期
【页码】627-635
【ISSN】1672-0415
【摘要】 Objective: To investigate how the National Health Commission of China-recommended Chinese medicines modulate the major maladjustments of coronavirus disease 2019,particularly the clinically observed complications and comorbidities. Methods: By focusi...
【基金】国家自然科学基金
【文献类型】期刊